ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gemcitabine Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35P8729
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gemcitabine Injection Market Outlook 2022
BUY CHAPTERS

Global Gemcitabine Injection Market Research Report 2025

Code: QYRE-Auto-35P8729
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fresenius Kabi
Teva Pharmaceuticals
Pfizer Inc
Mylan NV
Novartis
Accord Healthcare
Meitheal Pharmaceuticals

Gemcitabine Injection Market

The global market for Gemcitabine Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gemcitabine is used in combination with carboplatin to treat ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed) that returned at least 6 months after finishing a previous treatment. It also used in combination with paclitaxel (Abraxane, Taxol) to treat breast cancer that has not improved or that has worsened after treatment with other medications. Gemcitabine is used in combination with cisplatin to treat a type of lung cancer (non-small cell lung cancer; NSCLC) that has spread to other parts of the body and cannot be treated with surgery. Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in the body.
North American market for Gemcitabine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gemcitabine Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gemcitabine Injection include Fresenius Kabi, Teva Pharmaceuticals, Pfizer, Mylan Inc, Novartis AG, Accord Healthcare, Meitheal Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gemcitabine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Injection.
The Gemcitabine Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gemcitabine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gemcitabine Injection Market Report

Report Metric Details
Report Name Gemcitabine Injection Market
Segment by Type
  • 200mg/5.26 mL
  • 1g/26.3 mL
  • 2g/52.6 mL
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fresenius Kabi, Teva Pharmaceuticals, Pfizer, Mylan Inc, Novartis AG, Accord Healthcare, Meitheal Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gemcitabine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gemcitabine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gemcitabine Injection Market report?

Ans: The main players in the Gemcitabine Injection Market are Fresenius Kabi, Teva Pharmaceuticals, Pfizer, Mylan Inc, Novartis AG, Accord Healthcare, Meitheal Pharmaceuticals

What are the Application segmentation covered in the Gemcitabine Injection Market report?

Ans: The Applications covered in the Gemcitabine Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Gemcitabine Injection Market report?

Ans: The Types covered in the Gemcitabine Injection Market report are 200mg/5.26 mL, 1g/26.3 mL, 2g/52.6 mL

1 Gemcitabine Injection Market Overview
1.1 Product Definition
1.2 Gemcitabine Injection by Type
1.2.1 Global Gemcitabine Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 200mg/5.26 mL
1.2.3 1g/26.3 mL
1.2.4 2g/52.6 mL
1.3 Gemcitabine Injection by Application
1.3.1 Global Gemcitabine Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Gemcitabine Injection Market Size Estimates and Forecasts
1.4.1 Global Gemcitabine Injection Revenue 2020-2031
1.4.2 Global Gemcitabine Injection Sales 2020-2031
1.4.3 Global Gemcitabine Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gemcitabine Injection Market Competition by Manufacturers
2.1 Global Gemcitabine Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gemcitabine Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gemcitabine Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gemcitabine Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gemcitabine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gemcitabine Injection, Product Type & Application
2.7 Global Key Manufacturers of Gemcitabine Injection, Date of Enter into This Industry
2.8 Global Gemcitabine Injection Market Competitive Situation and Trends
2.8.1 Global Gemcitabine Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gemcitabine Injection Players Market Share by Revenue
2.8.3 Global Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gemcitabine Injection Market Scenario by Region
3.1 Global Gemcitabine Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gemcitabine Injection Sales by Region: 2020-2031
3.2.1 Global Gemcitabine Injection Sales by Region: 2020-2025
3.2.2 Global Gemcitabine Injection Sales by Region: 2026-2031
3.3 Global Gemcitabine Injection Revenue by Region: 2020-2031
3.3.1 Global Gemcitabine Injection Revenue by Region: 2020-2025
3.3.2 Global Gemcitabine Injection Revenue by Region: 2026-2031
3.4 North America Gemcitabine Injection Market Facts & Figures by Country
3.4.1 North America Gemcitabine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gemcitabine Injection Sales by Country (2020-2031)
3.4.3 North America Gemcitabine Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gemcitabine Injection Market Facts & Figures by Country
3.5.1 Europe Gemcitabine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gemcitabine Injection Sales by Country (2020-2031)
3.5.3 Europe Gemcitabine Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gemcitabine Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Gemcitabine Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gemcitabine Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Gemcitabine Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gemcitabine Injection Market Facts & Figures by Country
3.7.1 Latin America Gemcitabine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gemcitabine Injection Sales by Country (2020-2031)
3.7.3 Latin America Gemcitabine Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gemcitabine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Gemcitabine Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gemcitabine Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gemcitabine Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gemcitabine Injection Sales by Type (2020-2031)
4.1.1 Global Gemcitabine Injection Sales by Type (2020-2025)
4.1.2 Global Gemcitabine Injection Sales by Type (2026-2031)
4.1.3 Global Gemcitabine Injection Sales Market Share by Type (2020-2031)
4.2 Global Gemcitabine Injection Revenue by Type (2020-2031)
4.2.1 Global Gemcitabine Injection Revenue by Type (2020-2025)
4.2.2 Global Gemcitabine Injection Revenue by Type (2026-2031)
4.2.3 Global Gemcitabine Injection Revenue Market Share by Type (2020-2031)
4.3 Global Gemcitabine Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gemcitabine Injection Sales by Application (2020-2031)
5.1.1 Global Gemcitabine Injection Sales by Application (2020-2025)
5.1.2 Global Gemcitabine Injection Sales by Application (2026-2031)
5.1.3 Global Gemcitabine Injection Sales Market Share by Application (2020-2031)
5.2 Global Gemcitabine Injection Revenue by Application (2020-2031)
5.2.1 Global Gemcitabine Injection Revenue by Application (2020-2025)
5.2.2 Global Gemcitabine Injection Revenue by Application (2026-2031)
5.2.3 Global Gemcitabine Injection Revenue Market Share by Application (2020-2031)
5.3 Global Gemcitabine Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Company Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fresenius Kabi Gemcitabine Injection Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceuticals Gemcitabine Injection Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Gemcitabine Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Mylan Inc
6.4.1 Mylan Inc Company Information
6.4.2 Mylan Inc Description and Business Overview
6.4.3 Mylan Inc Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Inc Gemcitabine Injection Product Portfolio
6.4.5 Mylan Inc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Gemcitabine Injection Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Company Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Accord Healthcare Gemcitabine Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 Meitheal Pharmaceuticals
6.7.1 Meitheal Pharmaceuticals Company Information
6.7.2 Meitheal Pharmaceuticals Description and Business Overview
6.7.3 Meitheal Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Meitheal Pharmaceuticals Gemcitabine Injection Product Portfolio
6.7.5 Meitheal Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gemcitabine Injection Industry Chain Analysis
7.2 Gemcitabine Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gemcitabine Injection Production Mode & Process Analysis
7.4 Gemcitabine Injection Sales and Marketing
7.4.1 Gemcitabine Injection Sales Channels
7.4.2 Gemcitabine Injection Distributors
7.5 Gemcitabine Injection Customer Analysis
8 Gemcitabine Injection Market Dynamics
8.1 Gemcitabine Injection Industry Trends
8.2 Gemcitabine Injection Market Drivers
8.3 Gemcitabine Injection Market Challenges
8.4 Gemcitabine Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Fresenius Kabi
Teva Pharmaceuticals
Pfizer Inc
Mylan NV
Novartis
Accord Healthcare
Meitheal Pharmaceuticals
List of Tables
 Table 1. Global Gemcitabine Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gemcitabine Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gemcitabine Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gemcitabine Injection Sales (KL) of Key Manufacturers (2020-2025)
 Table 5. Global Gemcitabine Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gemcitabine Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gemcitabine Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gemcitabine Injection Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gemcitabine Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gemcitabine Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gemcitabine Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Gemcitabine Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gemcitabine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemcitabine Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gemcitabine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gemcitabine Injection Sales by Region (2020-2025) & (KL)
 Table 18. Global Gemcitabine Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Gemcitabine Injection Sales by Region (2026-2031) & (KL)
 Table 20. Global Gemcitabine Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Gemcitabine Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gemcitabine Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Gemcitabine Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gemcitabine Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Gemcitabine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gemcitabine Injection Sales by Country (2020-2025) & (KL)
 Table 27. North America Gemcitabine Injection Sales by Country (2026-2031) & (KL)
 Table 28. North America Gemcitabine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gemcitabine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gemcitabine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gemcitabine Injection Sales by Country (2020-2025) & (KL)
 Table 32. Europe Gemcitabine Injection Sales by Country (2026-2031) & (KL)
 Table 33. Europe Gemcitabine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gemcitabine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gemcitabine Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gemcitabine Injection Sales by Region (2020-2025) & (KL)
 Table 37. Asia Pacific Gemcitabine Injection Sales by Region (2026-2031) & (KL)
 Table 38. Asia Pacific Gemcitabine Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gemcitabine Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gemcitabine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gemcitabine Injection Sales by Country (2020-2025) & (KL)
 Table 42. Latin America Gemcitabine Injection Sales by Country (2026-2031) & (KL)
 Table 43. Latin America Gemcitabine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gemcitabine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gemcitabine Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gemcitabine Injection Sales by Country (2020-2025) & (KL)
 Table 47. Middle East and Africa Gemcitabine Injection Sales by Country (2026-2031) & (KL)
 Table 48. Middle East and Africa Gemcitabine Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gemcitabine Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gemcitabine Injection Sales (KL) by Type (2020-2025)
 Table 51. Global Gemcitabine Injection Sales (KL) by Type (2026-2031)
 Table 52. Global Gemcitabine Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Gemcitabine Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Gemcitabine Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gemcitabine Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gemcitabine Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Gemcitabine Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Gemcitabine Injection Price (US$/L) by Type (2020-2025)
 Table 59. Global Gemcitabine Injection Price (US$/L) by Type (2026-2031)
 Table 60. Global Gemcitabine Injection Sales (KL) by Application (2020-2025)
 Table 61. Global Gemcitabine Injection Sales (KL) by Application (2026-2031)
 Table 62. Global Gemcitabine Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Gemcitabine Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Gemcitabine Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gemcitabine Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gemcitabine Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Gemcitabine Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Gemcitabine Injection Price (US$/L) by Application (2020-2025)
 Table 69. Global Gemcitabine Injection Price (US$/L) by Application (2026-2031)
 Table 70. Fresenius Kabi Company Information
 Table 71. Fresenius Kabi Description and Business Overview
 Table 72. Fresenius Kabi Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Fresenius Kabi Gemcitabine Injection Product
 Table 74. Fresenius Kabi Recent Developments/Updates
 Table 75. Teva Pharmaceuticals Company Information
 Table 76. Teva Pharmaceuticals Description and Business Overview
 Table 77. Teva Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceuticals Gemcitabine Injection Product
 Table 79. Teva Pharmaceuticals Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. Pfizer Gemcitabine Injection Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Mylan Inc Company Information
 Table 86. Mylan Inc Description and Business Overview
 Table 87. Mylan Inc Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. Mylan Inc Gemcitabine Injection Product
 Table 89. Mylan Inc Recent Developments/Updates
 Table 90. Novartis AG Company Information
 Table 91. Novartis AG Description and Business Overview
 Table 92. Novartis AG Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 93. Novartis AG Gemcitabine Injection Product
 Table 94. Novartis AG Recent Developments/Updates
 Table 95. Accord Healthcare Company Information
 Table 96. Accord Healthcare Description and Business Overview
 Table 97. Accord Healthcare Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 98. Accord Healthcare Gemcitabine Injection Product
 Table 99. Accord Healthcare Recent Developments/Updates
 Table 100. Meitheal Pharmaceuticals Company Information
 Table 101. Meitheal Pharmaceuticals Description and Business Overview
 Table 102. Meitheal Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 103. Meitheal Pharmaceuticals Gemcitabine Injection Product
 Table 104. Meitheal Pharmaceuticals Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Gemcitabine Injection Distributors List
 Table 108. Gemcitabine Injection Customers List
 Table 109. Gemcitabine Injection Market Trends
 Table 110. Gemcitabine Injection Market Drivers
 Table 111. Gemcitabine Injection Market Challenges
 Table 112. Gemcitabine Injection Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gemcitabine Injection
 Figure 2. Global Gemcitabine Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gemcitabine Injection Market Share by Type: 2024 & 2031
 Figure 4. 200mg/5.26 mL Product Picture
 Figure 5. 1g/26.3 mL Product Picture
 Figure 6. 2g/52.6 mL Product Picture
 Figure 7. Global Gemcitabine Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gemcitabine Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Gemcitabine Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Gemcitabine Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Gemcitabine Injection Sales (2020-2031) & (KL)
 Figure 14. Global Gemcitabine Injection Average Price (US$/L) & (2020-2031)
 Figure 15. Gemcitabine Injection Report Years Considered
 Figure 16. Gemcitabine Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Gemcitabine Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Gemcitabine Injection Players: Market Share by Revenue in Gemcitabine Injection in 2024
 Figure 19. Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Gemcitabine Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Gemcitabine Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Gemcitabine Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Gemcitabine Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Gemcitabine Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Gemcitabine Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Gemcitabine Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Gemcitabine Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Gemcitabine Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Gemcitabine Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Gemcitabine Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Gemcitabine Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Gemcitabine Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Gemcitabine Injection by Type (2020-2031)
 Figure 55. Global Gemcitabine Injection Price (US$/L) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Gemcitabine Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Gemcitabine Injection by Application (2020-2031)
 Figure 58. Global Gemcitabine Injection Price (US$/L) by Application (2020-2031)
 Figure 59. Gemcitabine Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Gemcitabine Powder For Injection Market Research Report 2024
Global Gemcitabine Hydrochloride for Injection Market Research Report 2024
Global Topotecan Injection Market Research Report 2024
Global Paclitaxel and Docetaxel APIs Market Research Report 2024
Global Gemcitabine Hydrochloride Market Research Report 2025
Global Natural Paclitaxel Market Research Report 2024
Global Cabazitaxel Injection Market Research Report 2024
Global Taxane Antineoplastic Drug Market Research Report 2024
Global Irinotecan Hydrochloride Liposome Injection Market Research Report 2025
Global Cytarabine Injection Market Research Report 2024
Global Paclitaxel Injection Market Insights Forecast to 2030
Global Capecitabine Market Research Report 2025
Global Injectable Cytotoxic Drugs Market Research Report 2024
Cisplatin Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Taxol Market Research Report 2024
Global Cyclophosphamide Injection Market Research Report 2024
Global Platinum based Cancer Drug Market Insights Forecast to 2030
Global Irinotecan Market Research Report 2024
Global Carboplatin Injection Market Research Report 2024
Global Protein Bound Paclitaxel Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions